Back to results
US 12,692,325 B2Granted
Displacers of IgE-FceRI
AssigneesAlk-Abelló, Inc., Aarhus Universitet
InventorsEdzard Spillner, Sivelle Coline, Lars Harder Christensen, Peter Sejer Andersen, Gitte Lund, Teit Johansen, Frederic Jabs, Anne-Sofie Ravn Ballegaard, Andrea Maria Kemter
Life of this patent
Estimating the term…
Abstract
Disclosed are single domain antibody-based constructs, which are useful for treating IgE-related disorders or conditions by facilitating the dissociation of IgE from the high-affinity IgE receptor. Further disclosed are compositions comprising the constructs. Also nucleic acids and vectors are provides, as is methods of treatment of IgE related disorders.
Claims12
A multi-specific construct comprising
- a. a first single domain antibody (sdAb) able to displace bound IgE from FcϵRI,
- b. a second sdAb that binds to IgE,
- c. a moiety that links the first and second sdAb,
- wherein
- the first and second sdAb bind non-identical epitopes of IgE, and
- the multi-specific construct can displace bound IgE from the IgE high-affinity receptor (FcϵRI) with improved displacement activity compared to the first or second sdAb,
- wherein the moiety that links the first and second sdAb comprises
- an Fc region from an IgG antibody or from an Fc region comprising a mutation that induces heterodimerisation, and the first sdAb and second sdAb are fused or coupled covalently to the C-terminal end of a first Fc region polypeptide and a second Fc region polypeptide, respectively,
- wherein the first sdAb comprises a first CDR1, CDR2, and CDR3 binding regions each comprising or consisting of an amino acid sequence in the amino acid sequence set forth in SEQ ID NO:
- 1, wherein the amino acid sequence of the first CDR1, CDR2, and CDR3 binding regions are determined according to a single numbering scheme, wherein said numbering scheme is either Kabat, Chothia, IMTG or Aho numbering scheme, and
- the second sdAb comprises a second CDR1, CDR2, and CDR3 binding regions each comprising or consisting of an amino acid sequence in the amino acid sequence set forth in SEQ ID NO:
- 9 or 25, wherein the amino acid sequence of the second CDR1, CDR2, and CDR3 binding regions are determined according to a single numbering scheme, wherein said numbering scheme is either Kabat, Chothia, IMTG or Aho numbering scheme.
9 more elements
A multi-specific construct comprising:
- a. a first single domain antibody (sdAb) able to displace bound IgE from FcϵRI;
- b. a second sdAb that binds to IgE;
- and
- c. a Fc region,
- wherein the multi-specific construct comprises two polypeptides having the respective SEQ ID NOs:
- 94 and 102 or SEQ ID NOs:
- 94 and 338, wherein non-CDR regions of at least one of said polypeptides are modified to comprise human or humanized amino acid sequences;
- and wherein the multi-specific construct is able to displace bound IgE from FcϵRI with improved displacement activity compared to the first or second sdAb.
5 more elements
Dependencies are inferred from the claim text.